Statera Biopharma, Inc. Contract Liability (Deferred Revenue)
Statera Biopharma, Inc. had Contract Liability (Deferred Revenue) of $386.93 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2022-11-14
- 2022-09-30: Contract with Customer, Liability, Current $386.93K.
- 2022-06-30: Contract with Customer, Liability, Current $550.22K.
- 2022-03-31: Contract with Customer, Liability, Current $205.82K.
- 2021-12-31: Contract with Customer, Liability, Current $373.47K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2022-09-30 | $386.93K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $550.22K 10-Q · filed 2022-10-28 |
| 2022-03-31 | $205.82K 10-Q · filed 2022-10-21 |
| 2021-12-31 | $373.47K 10-Q · filed 2022-11-14 |
| 2021-09-30 | $506.03K 10-Q · filed 2021-11-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-10-06 |
| 2020-12-30 | $0.00 10-Q · filed 2021-11-15 |
| 2020-09-30 | $6.83K 10-Q · filed 2020-11-16 |